LIVMOR’s Atrial Fibrillation Monitor Gets FDA Clearance

The FDA has granted LIVMOR 510(k) clearance for its Halo AF Detection System, a smartwatch monitor that detects atrial fibrillation.

The noninvasive monitor tracks pulse rhythms to detect atrial fibrillation in the wearer. It operates on demand during the day and runs automatically at night.

The atrial fibrillation detection system is powered by the company’s Halo + digital home monitoring system, which runs on a Samsung Gear S2 smartwatch.